创新是我们的天性
对我们而言，产品开发和创新如影随形。我们旨在通过坚持不懈地探索新技术，寻求拓展产品组合地新机遇，向大众展现磷虾的巨大潜能。
PL+ TechnologyTM
PL+ 技术是一种基于磷脂的递送平台，旨在促进膳食补充剂的吸收。一些在胃肠道中的溶解度差的营养成分，如 DHA 和 EPA、姜黄素、辅酶 Q10 和叶黄素等，其在体内生物利用度和吸收不稳定。我们专有的 PL+ 技术可在水和脂肪中实现双重溶解，并提高几种重要营养素的生物利用度。
FloraMarineTM
FloraMarineTM 是一种来自藻类的新型植物型 DHA omega-3 油脂，提供目前市场上具有竞争力的的天然 DHA 含量。FloraMarine 品牌依托于Aker BioMarine，是大健康营养品行业值得信赖的海洋来源 omega-3 专家。
Superba Krill®
新一代磷虾油补充剂基于生产提取和纯化技术的持续优化，提供纯净的高浓度的磷脂的磷虾油，且不含污染物和重金属。
Lysoveta®
EPA 和 DHA 等必需脂肪酸已被证明对大脑、生殖器官、眼睛和皮肤等器官的健康功能很重要。突破性科学研究表明，EPA 和 DHA 通过名为 Mfsd2a 的转运蛋白以特定形式的 LPC 运输到这些器官。LYSOVETA® 是一种来自磷虾的富含溶血磷脂酰胆碱 （LPC） 脂质的提取物，为探索 EPA 和 DHA 靶向递送到重要器官提供了新的机会。
Understory®
Understory® 是 Aker BioMarine 的全新的蛋白质品牌。南极磷虾蛋白提供完整、均衡的氨基酸谱，并含有天然存在的矿物质，对支持和维持体内的重要功能很重要。通过我们的创新专利工艺，我们增强了这种来自天然资源的营养，并提供了独特的产品开发机会。
CaPre®
一种全新的候选治疗药物，用于管理和治疗心脏代谢疾病，尤其是对于严重的高甘油三酯血症患者，并且其副作用较低。CaPre 是一种独特的配方，是基于磷虾衍生的 EPA 和 DHA 的磷脂形式，无法合成且不易仿制。
KRBNX®
KRBNX® 提供下一代生物刺激素和肥料。KRBNX 以 Aker BioMarine 的一系列磷虾衍生产品为基础，是核心产品中的高质量副产品。对关键成分的科学报告指出，有机肥料、生物刺激素和土壤调理在农业中具有巨大潜力。
已授权和待定申请专利
以下是我们在最重要市场的专利权列表。
| Product Category | Country | Patent Number | Application Number | Issue Date | Title |
| Krill oil | AT | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | AU | 2008231570 | 2008231570 | 25-Jan-2012 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | AU | 2012101335 | 2012101335 | 20-Sep-2012 | PROCESSES AND PRODUCTS THEREOF |
| Krill oil | BE | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | CA | 2682068 | 2682068 | 28-Nov-2017 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | CH | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | DE | 60 2008 024 566.7 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | DK | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | EP | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | ES | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | FI | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | FR | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | GB | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | IE | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | IT | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | LU | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | NL | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | NO | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | PL | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | SE | 2144618 | 08718910.6 | 15-May-2013 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | US | 9,644,170 | 15/180,439 | 09-May-2017 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | US | 9,889,163 | 15/589,591 | 13-Feb-2018 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | US | 10,010,567 | 15/589,605 | 03-Jul-2018 | BIOEFFECTIVE KRILL OIL COMPOSITIONS |
| Krill oil | US | 8,697,138 | 12/790,575 | 15-Apr-2014 | METHODS OF USING KRILL OIL TO TREAT RISK FACTORS FOR CARDIOVASCULAR, METABOLIC, AND INFLAMMATORY DISORDERS |
| Krill oil | US | 9,730,966 | 14/968,183 | 15-Aug-2017 | METHOD OF REDUCING APPETITE IN A HUMAN SUBJECT COMPRISING ADMINISTERING KRILL OIL COMPOSITION |
| Krill oil | AU | 2016201168 | 14/035,167 | 12-Jul-2018 | LIPID EXTRACTION PROCESSES |
| Krill oil | EP | 3008156 | 2016201168 | 07-Jun-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | ES | 3008156 | 201480041687.1 | 07-Jun-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | GB | 3008156 | 14792582.0 | 07-Jun-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | NO | 3008156 | 14792582.0 | 07-Jun-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | PL | 3008156 | 14792582.0 | 07-Jun-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | UP | 3008156 | 14792582.0 | 07-Jun-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | US | 10,704,011 | 14792582.0 | 07-Jul-2020 | LIPID EXTRACTION PROCESSES |
| Krill oil | US | 11,578,289 | 14792582.0 | 14-Feb-2023 | LIPID EXTRACTION PROCESSES |
| Krill oil | AU | 2015205525 | 14/303,835 | 29-Mar-2018 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION |
| Krill oil | CA | 2936327 | 16/741,062 | 15-Dec-2020 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION |
| Krill oil | DE | 602015067174.0 | 2016-3119 | 24-Mar-2021 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION |
| Krill oil | EP | 3094337 | 15753445.4 | 24-Mar-2021 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION |
| Krill oil | GB | 3094337 | 15753445.4 | 24-Mar-2021 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION |
| Krill oil | US | 9,867,856 | 15753445.4 | 16-Jan-2018 | PHOSPHOLIPID COMPOSITIONS AND THEIR PREPARATION |
| Krill oil | US | 11,020,438 | 15753445.4 | 01-Jun-2021 | |
| Krill oil | US | 10,960,016 | 14/728,101 | 30-Mar-2021 | CAPSULES CONTAINING HIGH DOSES OF KRILL PHOSPHOLIPIDS |
| Krill oil | US | 10,806,742 | 14/965,433 | 20-Oct-2020 | LIQUID PHOSPHOLIPID-CONTAINING COMPOSITIONS FOR THE PREPARATION OF PHARMACEUTICALS |
| Krill oil | AU | 2016217566 | 2016217566 | 30-May-2019 | LIPID COMPOSITIONS |
| Krill oil | AU | 2019203314 | 2019203314 | 08-Apr-2021 | LIPID COMPOSITIONS |
| Krill oil | BR | BR1120170173107 | BR1120170173107 | 26-Jul-2022 | LIPID COMPOSITIONS |
| Krill oil | ID | IDP000067491 | P00201706018 | 18-Feb-2020 | LIPID COMPOSITIONS |
| Krill oil | KR | 10-2079747 | 10-2017-7025430 | 14-Feb-2020 | LIPID COMPOSITIONS |
| Krill oil | KR | 10-2310765 | 10-2020-7004436 | 01-Oct-2021 | LIPID COMPOSITIONS |
| Krill oil | KR | 10-2515207 | 10-2021-7031460 | 24-Mar-2023 | LIPID COMPOSITIONS |
| Krill oil | NZ | 735362 | 735362 | 30-Apr-2019 | LIPID COMPOSITIONS |
| Krill oil | NZ | 747847 | 747847 | 03-Oct-2023 | LIPID COMPOSITIONS |
| Krill oil | RU | 2718983 | 2017129161 | 15-Apr-2020 | LIPID COMPOSITIONS |
| Krill oil | US | 10,864,223 | 15/040,347 | 15-Dec-2020 | LIPID COMPOSITIONS |
| Krill oil | US | 11,819,509 | 17/116,418 | 21-Nov-2023 | LIPID COMPOSITIONS |
| Krill oil | CH | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | DE | 602016076191.2 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | EP | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | ES | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | FR | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | GB | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | IT | 502023000006120 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | NO | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | PL | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | PT | 3256003 | 16709814.4 | 09-Nov-2022 | LIPID EXTRACTION PROCESSES |
| Krill oil | US | 10,456,412 | 15/040,330 | 29-Oct-2019 | LIPID EXTRACTION PROCESSES |
| Krill oil | IL | 248521 | 2021-575425 | 31-Jul-2020 | KRILL OIL PREPARATIONS AND THEIR USES |
| Krill oil | US | 10,898,525 | 10-2022-7001848 | 26-Jan-2021 | KRILL OIL PREPARATIONS AND THEIR USES |
| Krill oil | US | 9,650,590 | 18/226,395 | 16-May-2017 | SEPARATION OF POLAR LIPIDS FROM KRILL OIL EXTRACT |
| Krill oil | US | 9,650,333 | 15/382,085 | 16-May-2017 | PROCESS FOR SEPARATING ASTAXANTHAN |
| Krill oil | AU | 2021254620 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | ||
| Krill oil | US | 18/511,243 | LIPID COMPOSITIONS | ||
| Krill oil | GB | 3143586 | USES FOR PHOSPHOLIPID COMPOSITIONS | ||
| Krill oil | WO | 202080054624.5 | USES FOR PHOSPHOLIPID COMPOSITIONS | ||
| Krill oil | CN | 17/903,208 | LIPID EXTRACTION PROCESSES | ||
| Krill oil | CN | 202111524749.2 | LIPID COMPOSITIONS | ||
| Krill oil | EP | 16716056.3 | LIPID COMPOSITIONS | ||
| Krill oil | US | 15/915,439 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | ||
| Lysoveta | EA | 043427 | IPR2017-00746 | 24-May-2023 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS |
| Lysoveta | ID | P00202005137 | 13/545,830 | 17-Apr-2023 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS |
| Lysoveta | US | 11,065,267 | P00202005137 | 20-Jul-2021 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS |
| Lysoveta | US | 12,076,333 | 17/370,703 | 03-Sep-2024 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS |
| Lysoveta | US | 10,117,882 | 21721272.9 | 06-Nov-2018 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS |
| Lysoveta | US | 10,525,068 | 2022-559535 | 07-Jan-2020 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS |
| Lysoveta | US | 11,400,105 | 10-2022-7037654 | 02-Aug-2022 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS |
| Lysoveta | US | 10,555,957 | PCT/IB2023/056584 | 11-Feb-2020 | METHODS AND COMPOSITIONS FOR ENRICHING DHA LEVELS IN THE BRAIN |
| Lysoveta | US | 11,744,864 | 16/734,850 | 05-Sep-2023 | METHOD OF TREATING EYE DISEASES WITH KRILL OIL |
| Lysoveta | KR | 201880086246.1 | 04-Sep-2024 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | |
| Lysoveta | AU | 2018-433 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | BR | 15/239,259 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | HK | 13/189,714 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | IL | 2018389595 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | MX | 202091399 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | NZ | 18855122.0 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | SG | 62021029120.4 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | AU | 19714777.0 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | BR | 19714777.0 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | EA | 19714777.0 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | IL | 19714777.0 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | MX | 15/307,764 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | NZ | 2020298105 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | AU | 20221173 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| Lysoveta | CA | IPR2017-00745 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | CN | IPR2017-00747 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | EP | 15/260,217 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | IN | BR1120200127051 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | JP | 3086416 | LYSOPHOSPHATIDYLCHOLINE COMPOSITIONS | ||
| Lysoveta | CA | 19714777.0 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | CN | 766794 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | EP | 19714777.0 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | JP | 17/745,104 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | KR | 248521 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | US | BR1120210254773 | PARENTERAL LYSOPHOSPHATIDYLCHOLINE FORMULATIONS SUCH AS LPC-DHA, LPC-EPA AND THEIR USE IN THERAPY | ||
| Lysoveta | US | 17/218,760 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS | ||
| Lysoveta | CA | 18/381,439 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| Lysoveta | CN | PCT/IB2023/060534 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| Lysoveta | EP | 15/976,481 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| Lysoveta | JP | 12/849,950 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| Lysoveta | KR | 16/180,564 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| Lysoveta | US | 17/874,677 | KRILL OIL COMPOSITION ENRICHED IN LPC-DHA AND LPC-EPA | ||
| PL+ | DE | 602013069676.4 | 95/001,819 | 03-Jun-2020 | OMEGA-3 COMPOSITIONS |
| PL+ | EP | 2897595 | 95/001,774 | 03-Jun-2020 | OMEGA-3 COMPOSITIONS |
| PL+ | GB | 2897595 | 13836209.0 | 03-Jun-2020 | OMEGA-3 COMPOSITIONS |
| PL+ | US | 10,105,376 | 20177787.7 | 23-Oct-2018 | OMEGA-3 COMPOSITIONS |
| PL+ | US | 11,147,841 | 16/582,618 | 19-Oct-2021 | ENHANCED OMEGA-3 FORMULATIONS |
| PL+ | US | 12,023,359 | 20734501.8 | 02-Jul-2024 | PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF BIOACTIVE COMPOUNDS |
| PL+ | NO | 202193176 | PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF BIOACTIVE COMPOUNDS | ||
| PL+ | WO | 289096 | PHOSPHOLIPID COMPOSITIONS FOR DELIVERY OF THERAPEUTIC COMPOUNDS | ||
| PL+ | EP | 13836209.0 | OMEGA-3 COMPOSITIONS | ||
| PL+ | US | 13836209.0 | OMEGA-3 COMPOSITIONS | ||
| Understory | AT | 3749339 | 202017030922 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | BE | 3749339 | 10-2020-7021085 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | CH | 3749339 | 11202005905T | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | DE | 3749339 | 16/229,031 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | DK | 3749339 | 17/370,703 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | EP | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | ES | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | FI | 3749339 | BR1120200153699 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | FR | 3749339 | 3089673 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | GB | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | HK | 40042861 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | IE | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | IS | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | IT | 3749339 | 22179865.5 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | JP | 7516717 | 19714777.0 | 08-Jul-2024 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | LU | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | NL | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | NO | 3749339 | 620210331521 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | PL | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | SE | 3749339 | 19714777.0 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | TR | 3749339 | 2020-541505 | 03-Aug-2022 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT |
| Understory | AU | 2020-554958 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT | ||
| Understory | BR | MX/a/2020/006529 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT | ||
| Understory | NZ | 19714777.0 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT | ||
| Understory | CA | 765594 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT | ||
| Understory | EP | 2019214524 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT | ||
| Understory | KR | 19714777.0 | MARINE PROTEIN HYDROLYSATE WITH LOW FLUORIDE AND TRIMETHYLAMIN CONTENT | ||
| Understory | US | 10-2020-7022227 | PROTEIN HYDROLYSATES | ||
| Krill oil | AR | 20100104020 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | ||
| Krill oil | BR | 1,12012E+12 | 1,12012E+12 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | CA | 2779162 | 2779162 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | CA | 2989078 | 2989078 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | CL | 57.287 | 57.287 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | CN | ZL201080059930.4 | ZL201080059930.4 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | CN | ZL 201410490601.5 | ZL 201410490601.5 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | IL | 219457 | 219457 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | IL | 262567 | 262567 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | JP | 5827625 | 5827625 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | MX | 331404 | 331404 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | MX | MX/a/2014/010299 | MX/a/2014/010299 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | MX | 371752 | 371752 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | NZ | 600167 | 600167 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | PA | 89014-01 | 89014-01 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | SA | 3448 | 3448 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | TW | I573591 | I573591 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | US | 8586567 | 8586567 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | US | 9475830 | 9475830 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | US | 10130644 | 10130644 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | SA | 2012/03367 | 2012/03367 | CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITIONS | |
| Krill oil | CA | 3099660 | APPARATUS FOR METERING AND DISPENSING VISCOUS SUBSTANCE | ||
| Krill oil | CN | 2,0198E+12 | APPARATUS FOR METERING AND DISPENSING VISCOUS SUBSTANCE | ||
| Krill oil | HK | 62021038860.4 | APPARATUS FOR METERING AND DISPENSING VISCOUS SUBSTANCE | ||
| Krill oil | US | 11326922 | 11326922 | APPARATUS FOR METERING AND DISPENSING VISCOUS SUBSTANCE | |
| Krill oil | AU | 2020220816 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | BR | 1,12021E+12 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | CA | 3129365 | 3129365 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | |
| Krill oil | CN | 2,0208E+12 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | HK | 62022054366.9 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | IS | 285426 | 285426 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | |
| Krill oil | JP | 2021-547326 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | KR | 10-2021-7028729 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | NZ | 779464 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS | ||
| Krill oil | US | 17/427685 | PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS |